Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis.
Marra AR, Kobayashi T, Suzuki H, Alsuhaibani M, Tofaneto BM, Bariani LM, Auler MA, Salinas JL, Edmond MB, Doll M, Kutner JM, Pinho JRR, Rizzo LV, Miraglia JL, Schweizer ML. Marra AR, et al. Among authors: miraglia jl. J Infect. 2022 Mar;84(3):297-310. doi: 10.1016/j.jinf.2021.12.035. Epub 2022 Jan 1. J Infect. 2022. PMID: 34982962 Free PMC article. Review.
Effectiveness of two coronavirus disease 2019 (COVID-19) vaccines (viral vector and inactivated viral vaccine) against severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in a cohort of healthcare workers.
Marra AR, Miraglia JL, Malheiros DT, Guozhang Y, Teich VD, da Silva Victor E, Pinho JRR, Cypriano A, Vieira LW, Polonio M, Ornelas RH, de Oliveira SM, Borges Junior FA, Shibata ARO, Schettino GPP, de Oliveira KG, Ferraz Santana RA, de Mello Malta F, Amgarten D, Boechat AL, Trecenti NMZ, Kobayashi T, Salinas JL, Edmond MB, Rizzo LV. Marra AR, et al. Among authors: miraglia jl. Infect Control Hosp Epidemiol. 2023 Jan;44(1):75-81. doi: 10.1017/ice.2022.50. Epub 2022 Mar 30. Infect Control Hosp Epidemiol. 2023. PMID: 35351217 Free PMC article.
Effectiveness of Heterologous Coronavirus Disease 2019 (COVID-19) Vaccine Booster Dosing in Brazilian Healthcare Workers, 2021.
Marra AR, Miraglia JL, Malheiros DT, Guozhang Y, Teich VD, da Silva Victor E, Rebello Pinho JR, Cypriano A, Vieira LW, Polonio M, Ornelas RH, de Oliveira SM, Borges Junior FA, Oler SCC, Schettino GPP, de Oliveira KG, Ferraz Santana RA, de Mello Malta F, Amgarten D, Boechat AL, Trecenti NMZ, Kobayashi T, Salinas JL, Edmond MB, Rizzo LV. Marra AR, et al. Among authors: miraglia jl. Clin Infect Dis. 2023 Feb 8;76(3):e360-e366. doi: 10.1093/cid/ciac430. Clin Infect Dis. 2023. PMID: 35639918 Free PMC article.
Risk factors for long coronavirus disease 2019 (long COVID) among healthcare personnel, Brazil, 2020-2022.
Marra AR, Sampaio VS, Ozahata MC, Lopes R, Brito AF, Bragatte M, Kalil J, Miraglia JL, Malheiro DT, Guozhang Y, Teich VD, Victor EDS, Pinho JRR, Cypriano A, Vieira LW, Polonio M, de Oliveira SM, Ricardo VCV, Maezato AM, Callado GY, Schettino GPP, de Oliveira KG, Santana RAF, Malta FM, Amgarten D, Boechat AL, Kobayashi T, Perencevich E, Edmond MB, Rizzo LV. Marra AR, et al. Among authors: miraglia jl. Infect Control Hosp Epidemiol. 2023 Dec;44(12):1972-1978. doi: 10.1017/ice.2023.95. Epub 2023 Jun 5. Infect Control Hosp Epidemiol. 2023. PMID: 37272468 Free PMC article.
Longer-term effectiveness of a heterologous coronavirus disease 2019 (COVID-19) vaccine booster in healthcare workers in Brazil.
Marra AR, Miraglia JL, Malheiro DT, Guozhang Y, Teich VD, Victor EDS, Pinho JRR, Cypriano A, Vieira LW, Polonio M, Ornelas RH, de Oliveira SM, Borges FA, Oler SCC, Ricardo VCV, Maezato AM, Callado GY, Schettino GPP, de Oliveira KG, Santana RAF, Malta FM, Amgarten D, Boechat AL, Kobayashi T, Salinas JL, Edmond MB, Rizzo LV. Marra AR, et al. Among authors: miraglia jl. Antimicrob Steward Healthc Epidemiol. 2023 Jun 22;3(1):e104. doi: 10.1017/ash.2023.173. eCollection 2023. Antimicrob Steward Healthc Epidemiol. 2023. PMID: 37396193 Free PMC article.
A seroprevalence survey of anti-SARS-CoV-2 antibodies among individuals 18 years of age or older living in a vulnerable region of the city of São Paulo, Brazil.
Miraglia JL, Nascimento Monteiro C, Giannecchini Romagnolo A, Xavier Gomes R, Pitangueiras Mangueira C, Aparecida Rosseto-Welter E, Gabriel Souza J, da Gloria Dos Santos M, Nogueira Dos Santos R, I Carvalho K, Bonfim D. Miraglia JL, et al. PLoS One. 2021 Jul 29;16(7):e0255412. doi: 10.1371/journal.pone.0255412. eCollection 2021. PLoS One. 2021. PMID: 34324603 Free PMC article.
Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients.
Miraglia JL, Abdala E, Hoff PM, Luiz AM, Oliveira DS, Saad CG, Laurindo IM, Viso AT, Tayra A, Pierrotti LC, Azevedo LS, Campos LM, Aikawa NE, Timenetsky Mdo C, Luna E, Cardoso MR, Guedes Jda S, Raw I, Kalil J, Precioso AR. Miraglia JL, et al. PLoS One. 2011;6(11):e27214. doi: 10.1371/journal.pone.0027214. Epub 2011 Nov 8. PLoS One. 2011. PMID: 22087267 Free PMC article. Clinical Trial.
29 results